Market Tracker

04/17 6:05pm ET

Nektar Therapeutics (NASDAQ:NKTR)

10.97
Data as of Apr 17
 -0.075 / -0.68%
Today’s Change
8.72
Today|||52-Week Range
15.34
-3.35%
Year-to-Date

Today’s Trading

Previous close11.05
Today’s open10.99
Day’s range10.69 - 11.24
Volume1,648,233
Average volume (3 months)1,422,866
Market cap$1.4B
Dividend yield--
Data as of 3:59pm ET, 04/17/2014

Growth & Valuation

Earnings growth (last year)+6.67%
Earnings growth (this year)+49.29%
Earnings growth (next 5 years)+19.88%
Revenue growth (last year)+83.42%
P/E ratioNM
Price/Sales8.82
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ARIAARIAD Pharmaceutical...+0.11+1.48%
KERXKeryx Biopharmaceuti...-0.46-3.30%
DYAXDyax Corp-0.07-1.03%
SGMOSangamo BioSciences ...-0.27-1.89%
Data as of 3:59pm ET, 04/17/2014

Financials

Next reporting dateMay 7, 2014
EPS forecast (this quarter)$0.15
Annual revenue (last year)$148.9M
Annual profit (last year)-$162.0M
Net profit margin-108.79%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Financial Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts